Advertisement
Screener

OptimizeRx Corporation (OPRX) Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable

3.1 / 5 stars · 53/86 Roast Me

OptimizeRx Corporation Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable

OptimizeRx Corporation (OPRX) reported Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable of $12.09 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-20.

Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Asset Acquisition, Consideration Transferred

us-gaap:AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable · last filed 2025-03-20

  • OptimizeRx Corporation asset acquisition consideration transferred equity interest issued and issuable for fiscal 2024 was $12.09M, a 0.00% decline from fiscal 2023.
  • OptimizeRx Corporation asset acquisition consideration transferred equity interest issued and issuable for fiscal 2023 was $12.09M.
Period endAsset Acquisition Consideration Transferred Equity Interest Issued And Issuable 12 month
2024-12-31$12.09M
10-K · filed 2025-03-20
2023-12-31$12.09M
10-K · filed 2024-04-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
TEN Holdings, Inc. (XHLD)United States$0.152B
Future FinTech Group Inc. (FTFT)$0.144B
Datavault AI Inc. (DVLT)United States$0.144B-1.77
RESOURCES CONNECTION, INC. (RGP)United States$0.129B-3.84
DHI GROUP, INC. (DHX)United States$0.205B132.15
COMSCORE, INC. (SCOR)United States$0.073B-6.35
Research Solutions, Inc. (RSSS)United States$0.071B27.67
Getty Images Holdings, Inc. (GETY)United States$0.068B-2.33
FiscalNote Holdings, Inc. (NOTE)United States$0.065B
Bridger Aerospace Group Holdings, Inc. (BAER)United States$0.049B-9.14